Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Drug of Abuse Testing Market Outlook

The drug of abuse testing market is estimated to capture a valuation of US$ 1.65 billion in 2023 and is projected to reach US$ 2.69 billion by 2033. The market is estimated to secure a CAGR of 5.3% during the forecast period.

The sales of drug abuse testing kits are rising due to the high demand for rapid and accurate drug testing equipment in forensic laboratories, hospitals, and senior citizen care centers.

Attribute Details
Market CAGR (2023 to 2033) 5.3%
Market Valuation (2023) US$ 1.65 billion
Market Valuation (2033) US$ 2.69 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How does the Advent of Drug Warning Systems Affect the Drug Abuse Testing Industry?

Substance use disorders (SUDs) have emerged as a burden on society. In many parts of the world, annual surveys of drug and substance use in households, schools, and workplaces serve as one of the primary sources of information that indicate illicit drug use.

Increasing prescription drug abuse rates underpin the importance of adequate testing and abuse detection. Research also has shown substantial comorbidity of SUDs with psychiatric disorders and physical health issues.

However, drug abuse mapping has its challenges, which hinder research prospects in substance abuse epidemiology from devising modern solutions for drug abuse epidemics. Further, it is imperative to pinpoint factors that link with individual vulnerabilities of SUDs, such as genetics and social and environmental risk factors.

As deaths associated with fentanyl and other psychostimulants continue to rise and new psychoactive continue to emerge, methods of drug administration are also evolving. There has been a substantial rise in vaping of cannabis among teenagers and adolescents. Further, the COVID-19 outbreak has triggered drug overdoses and changes in drug use behaviors among homebound individuals.

The National Drug Early Warning System has launched a new system incorporating real-time surveillance to detect early signs of potential drug abuse. It includes 18 sentinel sites that utilize modern surveillance methods and gather data rapidly, securely, and timely.

Data collection in real-time is estimated to provide a comprehensive characterization of drug use and the availability of on-ground epidemiologic investigations in high-priority areas of concern. Such developments and the implementation of novel drug abuse testing guidelines are expected to propel sales of drug abuse testing over the assessment period.

How is the Increasing Incidence of Drug Abuse among the Elderly Spurring Demand for Drug Abuse Testing?

Chronic pain is more common and complicated in the geriatric population. According to the National Institute of Health (NIH), up to 80% of patients with cancer and 77% with heart disease have reported persistent pain. Patients have been prescribed opioid medications for pain management-however, regular opioid usage results in addiction and compel patients to resort to cheaper drugs.

Besides this, the rising adoption of recreational marijuana for chronic pain management also fuels addiction problems. Ongoing research and medical trials indicate that medical marijuana can improve sleep hygiene, malnutrition, depression, and other side effects of cancer treatment.

Regular usage of marijuana for medical or recreational purposes leads to depression, impaired memory, adverse cardiovascular functions, altered judgment, and motor skills in the geriatric population. Cannabinoids can also interact with other prescription drugs and complicate pre-existing health issues in older adults.

As opioid dependence continues to rise, healthcare professionals and other medical institutes are running regular tests and screening of the elderly to diagnose signs of drug abuse early. It is expected to spur demand for drug abuse testing tools and equipment in hospitals and diagnostics.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Drug of Abuse Testing Market, 2018 to 2022 Historical Sales, Compared to 2023 to 2033 Future Outlook

As per Future Market Insights (FMI), the global market grew at a steady CAGR of 5.4% between 2018 and 2022. The market captured a valuation of US$ 1.2 billion in 2018 and US$ 1.5 billion in 2022.

Rising awareness regarding the high consumption of illicit drugs and overdose of prescribed medications is estimated to continue propelling demand for drug abuse testing systems. Additionally, increasing preference for on-the-spot and disposable testing methods for rapid drug abuse detection is expected to provide tailwinds to sales of drug abuse testing tools.

To gain a competitive edge, leading players operating in the global drug abuse testing market provide training on identifying and handling illicit drugs to law enforcement authorities through online services. Such initiatives are expected to create lucrative opportunities for drug abuse testing players over the forecast period.

Comparative Analysis of Adjacent Markets

Drug of Abuse Testing Market:

Attributes Drug of Abuse Testing Market
CAGR (2023 to 2033) 5.3%
Value (2023) US$ 1.65 billion
Value (2033) US$ 2.69 billion
Trends Increasing demand for drug testing abuse, maintaining a healthy lifestyle, expansion in point-of-care testing, and growing awareness.
Opportunities Rising government initiatives, expanding healthcare settings, adoption of advanced technologies, and workplace drug testing.

Self-testing Market:

Attributes Self-testing Market
CAGR (2023 to 2033) 5.6%
Value (2023) US$ 7.89 billion
Value (2033) US$ 13.6 billion
Trends A growing aging population, rising healthcare facilities, and increasing demand for cost-effective solutions.
Opportunities Growing advanced technologies such as portable self-testing devices, increasing awareness, raising huge investments, and user-friendly monitoring systems.

Medical Testing Market:

Attributes Medical Testing Market
CAGR (2023 to 2033) 4.8%
Value (2023) US$ 10.74 billion
Value (2033) US$ 17.16 billion
Trends Growing prevalence of chronic diseases, rising advanced technologies, and patient awareness.
Opportunities Innovation of medical testing devices, investment in research and development activities, and adoption of technologies, including artificial intelligence.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Drug of Abuse Testing for Cannabinoids to Gain Momentum

As per National Centre for Drug Abuse Statistics, around 16.9% of American adults currently use marijuana. Marijuana is widely accepted as a recreational drug and is considered ‘less risky’ than other substances such as alcohol, tobacco, and painkillers.

The growing popularity of cannabinoids can be attributed to their acceptance in modern society. As it is considered less harmful, there has been less incidence of marijuana overdose. However, in some countries, the consumption of marijuana is illegal, even for recreational purposes. Marijuana addiction is rare, although overuse can still result in dementia, cardiovascular issues, and breathing disorders.

Owing to these factors, FMI has projected sales of drugs for abuse testing for cannabinoids to continue gaining momentum through 2033.

Immunoassays to Remain Highly Sought-after Drug of Abuse Testing Technique

Demand for immunoassays is expected to rise steadily over the forecast period owing to a rising preference towards on-the-spot testing and higher adoption of disposable blood testing devices.

This technique is commonly used for drug testing in urine. Immunoassays are generally used for initial screening. Standard formats of immunoassays used for drugs of abuse comprise EMIT (enzyme multiplied immunoassay technique), CEDIA (cloned enzyme donor immunoassays technique), and KIMS (kinetic interaction of microparticle in solution).

Sales of Drug Abuse Testing Kit in Forensic Laboratories to Continue Rising

Forensic drug chemistry is applied to identify illegal substances in the criminal justice system. Chemists use characteristics such as the interaction of atoms and molecules and chemical signatures, unique to only those substances.

Forensic chemistry covers aspects including drugs, explosives, and poisons. As per FMI, forensic laboratories are projected to remain the prominent drug abuse testing end-users. Growing demand for accurate and proper testing of individuals consuming illicit drugs and retailing illegal substances is expected to propel sales of drug abuse testing in forensic laboratories over the assessment period.

Country-wise Insights

Countries Current Market Share
United States 25.5%
Germany 4%
Japan 3.3%
Countries Current Market CAGR
Australia 6.2%
China 6%
India 6.7%
United Kingdom 5.3%

What Factors Drive the United States Drug Abuse Testing Market?

The rising prevalence of opioid dependence in the United States is expected to continue boosting demand for drug abuse testing tools and equipment. Substance abuse rates during the COVID-19 pandemic have grown substantially in the country, with more individuals dependent on cannabinoids for stress and anxiety relief. The United States is dominating the global market by registering a maximum share of 25.5% by 2033.

As per the National Centre for Drug Abuse Statistics, 53 million individuals over 12 have used illegal or misused prescription drugs in 2020. Commonly abused prescribed stimulants include Adderall, Modafinil, Ritalin, and Concerta. Non-sanctioned use of these drugs leads to drug abuse.

In response to the growing drug dependence among individuals in the United States, manufacturers are launching effective and accurate drug abuse testing kits. Along with novel product launches, key manufacturers are collaborating with research institutes and local authorities to spread awareness regarding drug abuse. It is expected to propel sales of drug abuse testing in the United States over the forecast period.

How Does the United Kingdom Market Exhibit Consistent Growth?

The Centre for Social Justice determined that snowballing drug addiction in the United Kingdom has made it the 'addiction capital of Europe.' Increasing usage of legal substances, mainly alcohol, and the usage of Class A drugs comprising heroin, meth, cocaine, and other hallucinogens are compelling authorities to launch drug testing protocols.

Causalities due to substance abuse in the United Kingdom affect users, their communities, and society. Due to the increasing costs of lab-based screening tests, hospitals, and drug management authorities are adopting on-the-spot testing kits. Manufacturers are developing easy-to-use and disposable drug-of-abuse testing systems to cater to high demand from hospitals and forensic labs.

The factors above are anticipated to offer lucrative opportunities for drug abuse testing market players operating in Europe, placing the United Kingdom as an attractive pocket for sales in the forthcoming years. The United Kingdom is securing a CAGR of 5.3% in the global market by 2033.

Why is China Market Considered Lucrative Growth?

Consistent usage of illicit drugs can lead to adverse mental and physical health disorders, including cardiovascular diseases, fatal overdose, intentional or unintentional injuries, and even crime. China is registering a CAGR of 6% in the global market during the forecast period.

These issues later progress into clinical and social severity, difficulty managing daily activities, morbidity, and non-adherence to treatment. It, coupled with the growing prevalence of alcohol dependence in China, is compelling authorities to increase drug abuse testing among citizens.

Sales of drug abuse testing systems in China are expected to grow steadily. The presence of key manufacturers, along with the rapid expansion of the healthcare sector and easy availability of raw materials, are some factors expected to augment the market's growth through 2033.

Competitive Landscape

The top 5 players operating in the global market comprise Quest Diagnostics, Roche Holding AG, Siemens AG (Siemens Healthineers), and Thermo Fisher Scientific, Inc., the top players accounting for maximum sales in the market.

Leading players operating in the global drug of abuse testing market are focusing on research and development to launch novel testing tools that are more effective and accurate. Players also invest in mergers, acquisitions, collaborations, and partnerships to expand their global footprint.

Other Essential Players in the Global Market are:

  • Quest Diagnostics
  • Roche Holding AG
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Abbott Laboratories (Alere, Inc.)
  • Shimadzu Corporation
  • Express Diagnostics International Inc.
  • Drägerwerk AG & Co. KGaA
  • Laboratory Corporation of America Holdings.

Recent Developments in the Global Market are:

Abbott Laboratories partnered with Intoximeters in August 2019, allowing the latter to market Abbott's SoToxaTM Mobile Test System. This is a handheld solution for oral fluid roadside testing. It has been designed to enable rapid detection of recent drug use.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered The United States, The United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered
  • Drug Type
  • Technique
  • End User
  • Region
Key Companies Profiled
  • Quest Diagnostics
  • Roche Holding AG
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Abbott Laboratories (Alere, Inc.)
  • Shimadzu Corporation
  • Express Diagnostics International Inc.
  • Drägerwerk AG & Co. KGaA
  • Laboratory Corporation of America Holdings.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Drug of Abuse Testing Market by Category

By Drug Type:

  • Psychostimulants
  • Narcotic
  • Cannabinoids
  • Sedatives
  • Others

By Technique:

  • Immunoassay
  • Chromatography
  • Rapid Testing

By End User:

  • Hospitals
  • Diagnostics Laboratories
  • Forensic Laboratories
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

Frequently Asked Questions

What will be the Global Drug of Abuse Testing Market Size Value in 2023?

In the current year 2023, the overall market size could be around US$ 1.65 billion.

What is the Expected CAGR for Global Drug of Abuse Testing Services?

Until 2033, the overall demand for drug of abuse testing services could progress at 5.3% CAGR.

How Drug of Abuse Testing Market Players are Performing in the United States?

The United States market players contributed for about 25.5% of the global market revenue in 2022.

What is the Share of Germany in Adoption of Drug of Abuse Testing Services?

Adoption of drug of abuse testing services in Germany held almost 4% market share in 2022.

Which Test Type of Drug of Abuse Testing Mostly Remains in Higher Demand?

The immunoassays testing type segment remains in higher demand for on-spot detection.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Drug Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drug Type, 2023 to 2033

        5.3.1. Psychostimulants

        5.3.2. Narcotic

        5.3.3. Cannabinoids

        5.3.4. Sedatives

        5.3.5. Others

    5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Drug Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technique

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Technique, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technique, 2023 to 2033

        6.3.1. Immunoassay

        6.3.2. Chromatography

        6.3.3. Rapid Testing

    6.4. Y-o-Y Growth Trend Analysis By Technique, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Technique, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Diagnostics Laboratories

        7.3.3. Forensic Laboratories

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Drug Type

        9.2.3. By Technique

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Drug Type

        9.3.3. By Technique

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Drug Type

        10.2.3. By Technique

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Drug Type

        10.3.3. By Technique

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Drug Type

        11.2.3. By Technique

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Type

        11.3.3. By Technique

        11.3.4. By End User

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Drug Type

        12.2.3. By Technique

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drug Type

        12.3.3. By Technique

        12.3.4. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Drug Type

        13.2.3. By Technique

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drug Type

        13.3.3. By Technique

        13.3.4. By End User

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Drug Type

        14.2.3. By Technique

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drug Type

        14.3.3. By Technique

        14.3.4. By End User

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Drug Type

        15.2.3. By Technique

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Drug Type

        15.3.3. By Technique

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Drug Type

            16.1.2.2. By Technique

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Drug Type

            16.2.2.2. By Technique

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Drug Type

            16.3.2.2. By Technique

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Drug Type

            16.4.2.2. By Technique

            16.4.2.3. By End User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Drug Type

            16.5.2.2. By Technique

            16.5.2.3. By End User

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Drug Type

            16.6.2.2. By Technique

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Drug Type

            16.7.2.2. By Technique

            16.7.2.3. By End User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Drug Type

            16.8.2.2. By Technique

            16.8.2.3. By End User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Drug Type

            16.9.2.2. By Technique

            16.9.2.3. By End User

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Drug Type

            16.10.2.2. By Technique

            16.10.2.3. By End User

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Drug Type

            16.11.2.2. By Technique

            16.11.2.3. By End User

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Drug Type

            16.12.2.2. By Technique

            16.12.2.3. By End User

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Drug Type

            16.13.2.2. By Technique

            16.13.2.3. By End User

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Drug Type

            16.14.2.2. By Technique

            16.14.2.3. By End User

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Drug Type

            16.15.2.2. By Technique

            16.15.2.3. By End User

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Drug Type

            16.16.2.2. By Technique

            16.16.2.3. By End User

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Drug Type

            16.17.2.2. By Technique

            16.17.2.3. By End User

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Drug Type

            16.18.2.2. By Technique

            16.18.2.3. By End User

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Drug Type

            16.19.2.2. By Technique

            16.19.2.3. By End User

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Drug Type

            16.20.2.2. By Technique

            16.20.2.3. By End User

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Drug Type

            16.21.2.2. By Technique

            16.21.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Drug Type

        17.3.3. By Technique

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Quest Diagnostics

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Roche Holding AG

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Thermo Fisher Scientific, Inc.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Siemens AG (Siemens Healthineers)

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Abbott Laboratories (Alere, Inc.)

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Shimadzu Corporation

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Express Diagnostics International Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Drägerwerk AG & Co. KGaA

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Laboratory Corporation of America Holdings.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Bio-Rad Laboratories, Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: South Asia Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 19: South Asia Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 20: South Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: East Asia Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 23: East Asia Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 24: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: Oceania Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 27: Oceania Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 28: Oceania Market Value (US$ Million) Forecast by End User, 2018 to 2033

Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 30: MEA Market Value (US$ Million) Forecast by Drug Type, 2018 to 2033

Table 31: MEA Market Value (US$ Million) Forecast by Technique, 2018 to 2033

Table 32: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Technique, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 17: Global Market Attractiveness by Drug Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Technique, 2023 to 2033

Figure 19: Global Market Attractiveness by End User, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Technique, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End User, 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 37: North America Market Attractiveness by Drug Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Technique, 2023 to 2033

Figure 39: North America Market Attractiveness by End User, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Technique, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End User, 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Drug Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Technique, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Technique, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End User, 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 77: Europe Market Attractiveness by Drug Type, 2023 to 2033

Figure 78: Europe Market Attractiveness by Technique, 2023 to 2033

Figure 79: Europe Market Attractiveness by End User, 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: South Asia Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 82: South Asia Market Value (US$ Million) by Technique, 2023 to 2033

Figure 83: South Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: South Asia Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 91: South Asia Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 94: South Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 95: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 97: South Asia Market Attractiveness by Drug Type, 2023 to 2033

Figure 98: South Asia Market Attractiveness by Technique, 2023 to 2033

Figure 99: South Asia Market Attractiveness by End User, 2023 to 2033

Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033

Figure 101: East Asia Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 102: East Asia Market Value (US$ Million) by Technique, 2023 to 2033

Figure 103: East Asia Market Value (US$ Million) by End User, 2023 to 2033

Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: East Asia Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 111: East Asia Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 114: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 115: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 117: East Asia Market Attractiveness by Drug Type, 2023 to 2033

Figure 118: East Asia Market Attractiveness by Technique, 2023 to 2033

Figure 119: East Asia Market Attractiveness by End User, 2023 to 2033

Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 121: Oceania Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 122: Oceania Market Value (US$ Million) by Technique, 2023 to 2033

Figure 123: Oceania Market Value (US$ Million) by End User, 2023 to 2033

Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: Oceania Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 131: Oceania Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 134: Oceania Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 137: Oceania Market Attractiveness by Drug Type, 2023 to 2033

Figure 138: Oceania Market Attractiveness by Technique, 2023 to 2033

Figure 139: Oceania Market Attractiveness by End User, 2023 to 2033

Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033

Figure 141: MEA Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 142: MEA Market Value (US$ Million) by Technique, 2023 to 2033

Figure 143: MEA Market Value (US$ Million) by End User, 2023 to 2033

Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: MEA Market Value (US$ Million) Analysis by Drug Type, 2018 to 2033

Figure 149: MEA Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 151: MEA Market Value (US$ Million) Analysis by Technique, 2018 to 2033

Figure 152: MEA Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033

Figure 154: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 157: MEA Market Attractiveness by Drug Type, 2023 to 2033

Figure 158: MEA Market Attractiveness by Technique, 2023 to 2033

Figure 159: MEA Market Attractiveness by End User, 2023 to 2033

Figure 160: MEA Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Sports Drug Testing Market

Published : July 2022

Explore Healthcare Insights

View Reports

Drug of Abuse Testing Market